###begin article-title 0
Genetic polymorphisms and susceptibility to lung disease
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 49 68 49 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus anthracis </italic>
###xml 761 769 761 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p47phox </italic>
###xml 770 774 770 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF1</italic>
###xml 777 785 777 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p67phox </italic>
###xml 786 790 786 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF2</italic>
###xml 793 801 793 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p40phox </italic>
###xml 802 806 802 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF4</italic>
###xml 809 817 809 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p22phox </italic>
###xml 818 822 818 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYBA</italic>
###xml 825 834 825 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gp91phox </italic>
###xml 835 839 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYBB</italic>
###xml 842 847 842 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUOX1</italic>
###xml 849 854 849 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUOX2</italic>
###xml 856 860 856 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2</italic>
###xml 862 867 862 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 </italic>
###xml 892 895 892 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AAT</italic>
###xml 49 67 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 91 95 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 133 139 <span type="species:ncbi:9606">humans</span>
###xml 156 161 <span type="species:ncbi:9606">human</span>
###xml 182 189 <span type="species:ncbi:1392">anthrax</span>
###xml 243 250 <span type="species:ncbi:1392">anthrax</span>
###xml 691 698 <span type="species:ncbi:1392">anthrax</span>
Susceptibility to infection by bacterium such as Bacillus anthracis has a genetic basis in mice and may also have a genetic basis in humans. In the limited human cases of inhalation anthrax, studies suggest that not all individuals exposed to anthrax spores were infected, but rather, individuals with underlying lung disease, particularly asthma, sarcoidosis and tuberculosis, might be more susceptible. In this study, we determined if polymorphisms in genes important in innate immunity are associated with increased susceptibility to infectious and non-infectious lung diseases, particularly tuberculosis and sarcoidosis, respectively, and therefore might be a risk factor for inhalation anthrax. Examination of 45 non-synonymous polymorphisms in ten genes: p47phox (NCF1), p67phox (NCF2), p40phox (NCF4), p22phox (CYBA), gp91phox (CYBB), DUOX1, DUOX2, TLR2, TLR9 and alpha 1-antitrypsin (AAT) in a cohort of 95 lung disease individuals and 95 control individuals did not show an association of these polymorphisms with increased susceptibility to lung disease.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 25 44 25 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus anthracis </italic>
###xml 226 245 226 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus anthracis </italic>
###xml 305 306 305 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 468 487 468 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus anthracis </italic>
###xml 488 489 488 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 620 621 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 699 700 699 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 701 702 701 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 784 803 784 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus anthracis </italic>
###xml 841 842 841 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 25 43 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 195 202 <span type="species:ncbi:1392">anthrax</span>
###xml 226 244 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 369 376 <span type="species:ncbi:1392">anthrax</span>
###xml 468 486 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 635 639 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 678 685 <span type="species:ncbi:1392">anthrax</span>
###xml 739 743 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 784 802 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 835 839 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 915 921 <span type="species:ncbi:9606">humans</span>
###xml 1141 1148 <span type="species:ncbi:1392">anthrax</span>
Since October 2001, when Bacillus anthracis was released in the United States as an act of bioterrorism, there has been a greater interest in determining if there are risk factors for inhalation anthrax infection. Exposure to Bacillus anthracis spores does not cause infection in all exposed individuals [1]. Epidemiologic studies of individuals infected by inhalation anthrax have suggested that a weakened immune system might increase susceptibility to infection by Bacillus anthracis [2]. Some of the infected individuals had a history of chronic pulmonary disease, including asthma, sarcoidosis, and tuberculosis [2-4]. Studies in mice have demonstrated a genetic basis for anthrax sensitivity [5,6]. For example, macrophages from C3H mice are 100,000 times more sensitive to the Bacillus anthracis toxin than macrophages from A/J mice [6]. The current study examines whether there are genetic polymorphisms in humans associated with increased susceptibility to lung disease. Identification of genes associated with an increased risk of lung disease might identify individuals who might also be of increased susceptibility to inhalation anthrax infection.
###end p 4
###begin p 5
###xml 4 5 4 5 <bold xmlns:xlink="http://www.w3.org/1999/xlink">N</bold>
###xml 12 14 12 14 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ox</bold>
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 840 847 840 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p47phox</italic>
###xml 849 857 849 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gp91phox</italic>
###xml 859 866 859 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p67phox</italic>
###xml 872 880 872 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p22phox </italic>
The NAD(P)H oxidases (NOX) are a family of enzymes that are essential in host defense against microbial infection, as reviewed by Quinn and Gauss [7]. The central enzyme of the NAD(P)H oxidase is a flavin and heme-containing protein, the most well known being the phagocytic gp91phox (CYBB, NOX2) protein. gp91phox, and a number of related proteins including DUOX1 and DUOX2, are transmembrane proteins which transport electrons and generate reactive oxygen species (ROS) at the expense of NADH or NADPH. The activity of the oxidases are highly regulated by accessory proteins, including p22phox (CYBA), p47phox (NOXO1, NCF1), p67phox (NOXA2, NCF2), and p40phox (NCF4). Chronic Granulomatous Disease (CGD), associated with severe, recurrent, and chronic non-specific bacterial and fungal infections, is most commonly caused by mutations in p47phox, gp91phox, p67phox, and p22phox that severely compromise the respiratory burst activity of neutrophils.
###end p 5
###begin p 6
###xml 93 101 93 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p47phox </italic>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF1</italic>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF1 </italic>
###xml 317 318 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 417 421 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF1</italic>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 605 609 605 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF1</italic>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 736 741 736 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF1 </italic>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1068 1075 1068 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p47phox</italic>
###xml 1077 1085 1077 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p67phox </italic>
###xml 1089 1097 1089 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gp91phox</italic>
###xml 1180 1188 1180 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p47phox </italic>
###xml 1272 1274 1272 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1303 1311 1303 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p22phox </italic>
###xml 1312 1316 1312 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYBA</italic>
###xml 1392 1394 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1472 1474 1472 1474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1475 1477 1475 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1548 1549 1548 1549 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1550 1552 1550 1552 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1553 1555 1553 1555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1556 1558 1556 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1570 1572 1570 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1672 1678 1672 1678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUOX2 </italic>
###xml 1737 1739 1737 1739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1740 1742 1740 1742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1141 1146 <span type="species:ncbi:9606">human</span>
###xml 1266 1270 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 1373 1378 <span type="species:ncbi:9606">human</span>
Gorlach et al were the first to identify the presence of at least one pseudogene copy of the p47phox (NCF1) gene on chromosome 7q11.23 [8]. By construction of a detailed physical map of this region Hockenhull et al determined that there were one normal wildtype copy and two pseudogene copies of NCF1 per chromosome [9]. Heyworth et al elegantly demonstrated that in some individuals, one of the pseudogene copies of NCF1, possibly by recombination or gene conversion, has reverted to the normal wildtype GTGT sequence (i.e. pseudowildtype) [10]. Thus, individuals with this low frequency polymorphism of NCF1, have 2 "wildtype" copies and one pseudogene copy per chromosome [10]. Therefore, individuals (with 2 chromosomes) can have a NCF1 pseudogene: wt copy ratio of either 2:1, 1:1 or 1:2. Although two groups have examined the association of the minor 1:1 and 1:2 alleles with inflammatory bowel disease, the conclusions were in conflict primarily due to differences in allele frequencies of the control population and sample size [11,12]. Other polymorphisms in p47phox, p67phox and gp91phox, have not been shown to be associated with human disease other than CGD. Recently p47phox has been shown by positional cloning to regulate the severity of arthritis in rats [13]. The H72Y polymorphisms in p22phox (CYBA), associated with reduced respiratory burst in isolated human neutrophils [14], but has yet to be shown to be clearly associated with a disease phenotype [15-17]. DUOX1 and DUOX2, which are expressed in lung epithelium, regulates H2O2 [18-20] and acid [21] production in the airway but have not been shown to be associated with lung disease. Mutations in DUOX2 have been shown to be associated with mild hypothyroidism [22-24].
###end p 6
###begin p 7
###xml 272 291 272 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus anthracis </italic>
###xml 402 421 402 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus anthracis </italic>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 792 797 792 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1101 1121 1101 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Borrelia burgdorferi</italic>
###xml 1150 1152 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1216 1238 1216 1238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus </italic>
###xml 1249 1251 1249 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 116 123 <span type="species:ncbi:1392">Anthrax</span>
###xml 216 220 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 272 290 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 402 420 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 554 558 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 562 567 <span type="species:ncbi:9606">human</span>
###xml 676 680 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 777 781 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 851 857 <span type="species:ncbi:9606">humans</span>
###xml 1101 1121 <span type="species:ncbi:139">Borrelia burgdorferi</span>
###xml 1216 1237 <span type="species:ncbi:1280">Staphylococcus aureus</span>
TLR2 is the receptor for peptidoglycans, lipoteichoic acid, lipoarabinomannan, mycolylarabinogalactan, and zymosan. Anthrax infection is thought to be partially mediated through the TLR2 pathway since TLR2 deficient mice are resistant to infection by the Sterne strain of Bacillus anthracis and HEK293 cells expressing TLR2, but not TLR4, are able to signal in response to exposure to heat-inactivated Bacillus anthracis [25]. Inactivation and killing of the tuberculosis mycobacterium is also mediated through TLR2 since macrophages from Tlr2-deficient mice or human macrophages blocked by anti-TLR2 antibodies failed to kill the bacteria [26]. Tlr9 and Tlr2 double knockout mice display a more pronounced susceptibility to infection by tuberculosis than single gene knockout mice [27]. The TLR2 polymorphism R753Q [28] and the R677W polymorphism in humans [29-31] have been shown to be associated with increase risk for tuberculosis infection. The R753Q polymorphism was not associated with a generalized increased risk of infection, e.g. individuals with R753Q were less responsive to infection by Borrelia burgdorferi, which causes Lyme Disease [32] and R753Q was not associated with increased susceptibility to Staphylococcus aureus infection [33].
###end p 7
###begin p 8
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AAT </italic>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 677 681 677 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AAT </italic>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 915 917 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 511 517 <span type="species:ncbi:9606">people</span>
Alpha-1-anti-trypsin (AAT) deficiency has been associated with increased susceptibility to lung disease, particularly emphysema [34,35]. Although more than 70 variants have been described, only a few are associated with reduced AAT protein expression and/or reduced activity [35]. Several studies have suggested that simple heterozygosity for mutant alleles of AAT may predispose individuals to chronic obstructive lung disease [35-37]. The Z allele (E366K), which occurs at an allele frequency of 0.01-0.02 in people of European origin, is the most common allele associated with an increased risk of environmentally induced emphysema [34,38-40]. Homozygous individuals of the AAT S allele (E288V) are not at risk for emphysema but compound heterozygotes of the Z and S allele or a null allele are of increased risk [39,41]. Carriers of the AAT S and Z alleles are over-represented in individuals with lung cancer [42]
###end p 8
###begin p 9
###xml 226 234 226 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p47phox </italic>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF1</italic>
###xml 242 250 242 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p67phox </italic>
###xml 251 255 251 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF2</italic>
###xml 258 266 258 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p40phox </italic>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF4</italic>
###xml 274 283 274 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gp91phox </italic>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYBB</italic>
###xml 291 299 291 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p22phox </italic>
###xml 300 304 300 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYBA</italic>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUOX1</italic>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUOX2</italic>
###xml 321 325 321 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2</italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 </italic>
###xml 358 361 358 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AAT</italic>
In this study, we attempted to determine whether normal nonsynonymous genetic variations identified by the Genbank SNP database or previously described in the literature to be present in the normal population in the genes for p47phox (NCF1), p67phox (NCF2), p40phox (NCF4), gp91phox (CYBB), p22phox (CYBA), DUOX1, DUOX2, TLR2, TLR9 and alpha-1 anti-trypsin (AAT) are associated with an increased susceptibility to tuberculosis, sarcoidosis, recurrent pneumonia, and atypical mycobacterial infection.
###end p 9
###begin title 10
Materials and methods
###end title 10
###begin title 11
###xml 6 18 <span type="species:ncbi:9606">participants</span>
Study participants
###end title 11
###begin p 12
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 224 236 <span type="species:ncbi:9606">participants</span>
###xml 608 620 <span type="species:ncbi:9606">participants</span>
###xml 789 794 <span type="species:ncbi:9606">human</span>
###xml 888 893 <span type="species:ncbi:9606">human</span>
Anonymized blood samples from control individuals of European, non-Hispanic origin (n = 95) were obtained from Kaiser Permanente [43] or from The Scripps Research Institute GCRC blood drawing program. From a group of 31,247 participants in a Kaiser Permanente study of European, non-Hispanic origin [43], all individuals that had a documented medical history with hospitalization for lung diseases: atypical mycobacterial infection (n = 1), repeated episodes of pneumonia (n = 5), sarcoidosis (n = 46), and tuberculosis (n = 43), were selected and will be referred to as the lung disease group (n = 95). The participants in the Kaiser Permanente study were members of Kaiser Permanente attending a Health Appraisal Clinic and were not selected for underlying acute or chronic disease. All human samples were obtained with written consent. Approvals for the protocols involving the use of human individuals were obtained from the institutional review boards of The Scripps Research Institute and Kaiser Permanente.
###end p 12
###begin title 13
p47phox/NCF1 pseudogene: wildtype ratio
###end title 13
###begin p 14
###xml 235 237 235 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 321 323 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
Amplification of the region of p47phox exon 2 with the wildtype GTGT sequence and the pseudogene delGT sequence were amplified using primers p47phox/NCF1 Ex2F GCTTCCTCCAGTGGGTAGTGGGATC and p47phox/NCF 161R GGAACTCGTAGATCTCGGTGAAGC and 32P-labeled p47phox/NCF1 Ex2F primer under standard PCR conditions for 25 cycles. The 32P-labeled amplified DNA products were separated on a 10% acrylamide/urea/TBE sequencing gel. Autoradiography was used to visualize the wildtype and pseudogene amplified products, which differ by 2 nucleotides in length.
###end p 14
###begin title 15
Genotyping of single nucleotide polymorphisms (SNPs) by allele specific oligomer hybridization (ASOH)
###end title 15
###begin p 16
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 334 336 334 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
For the genes of this study, non-synonymous SNPs identified in Genbank's SNP database and/or non-synonynous SNPs associated with lung disease were investigated. Amplification of DNA regions encompassing the SNPs were amplified using the primers listed in Table 1. ASOH was performed using standard hybridization conditions [44] using 32P radiolabeled probes and washing temperatures described in Table 1. Genotyping was determined following visualization of the hybridized probe by autoradiography.
###end p 16
###begin p 17
Primer List. List of primers used for DNA amplification and ASOH.
###end p 17
###begin title 18
Statistics
###end title 18
###begin p 19
The Fisher's Exact test was performed with GraphPad InStat using the raw data entered into a 2 x 2 contingency table. Power calculations were performed to give the probability of finding the differences between the gene frequencies as statistically significant, given the sample size.
###end p 19
###begin title 20
Results
###end title 20
###begin p 21
We examined 95 individuals of European, non-Hispanic origin with documented medical history with hospitalization for lung disease (46 with sarcoidosis, 43 with tuberculosis, five with recurrent pneumonia, and one with atypical mycobacterial infection) and 95 control individuals of European, non-Hispanic origin for differences in allele frequencies in genes involved in innate immunity.
###end p 21
###begin title 22
P47phox/(NCF1)
###end title 22
###begin p 23
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
Examination of the pseudogene: wt copy ratio of control versus lung disease individuals demonstrated no statistically significant difference in the frequencies of the pseudogene: wt ratios in the lung disease group as compared to the control group (Table 2).
###end p 23
###begin p 24
Pseudogene versus gene ratio. p47phox/NCF1 pseudogene: wt gene ratio in lung disease and control individuals. The data are presented as number of individuals with the indicated pseudogene:wt ratio and the number within parentheses indicates the calculated frequency.
###end p 24
###begin title 25
p67phox (NCF2), p40phox (NCF4), p22phox (CYBA), gp91phox (CYBB), DUOX1, DUOX2
###end title 25
###begin p 26
###xml 12 20 12 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p67phox </italic>
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF2</italic>
###xml 28 36 28 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p40phox </italic>
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF4</italic>
###xml 44 52 44 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p22phox </italic>
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYBA</italic>
###xml 63 72 63 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gp91phox </italic>
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYBB</italic>
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUOX1 </italic>
###xml 90 96 90 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUOX2 </italic>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
SNPs in the p67phox (NCF2), p40phox (NCF4), p22phox (CYBA) and gp91phox (CYBB), DUOX1 and DUOX2 genes were examined. Some SNPs did not occur at a high enough frequency to be detected in our samples. None of the allele frequencies differed significantly between the lung disease and the control groups (Table 3).
###end p 26
###begin p 27
Summary of SNP Analyses. SNP analyses of candidate genes in lung disease versus control groups. Numbering of SNPs start from the ATG initiator methionine of the cDNA. Data are presented as number of alleles identified divided by total number of alleles examined. Numbers within parentheses are the calculated allele frequencies. Power calculations were performed using number of subjects.
###end p 27
###begin title 28
TLR2, TLR9, AAT
###end title 28
###begin p 29
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2</italic>
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9</italic>
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AAT </italic>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2 </italic>
###xml 581 585 581 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AAT </italic>
###xml 787 788 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
TLR2, TLR9, and AAT genes were examined. Again, many SNPs did not occur at high enough frequency to be observed. Most of the allele frequencies did not differ between the lung disease and control groups. The TLR2 polymorphism R753Q, associated with tuberculosis, was not shown to be different between the control or lung disease group. The TLR2 R677W polymorphism, also associated with tuberculosis, was not observed in either group. The R863Q SNP in TLR9 was absent from the lung disease group indicating that this polymorphism was not associated with increased lung disease. The AAT S (Glu288Val) and Z (E366K) alleles, associated with chronic obstructive lung disease, were examined and there was no difference in allele frequencies between the control and lung disease groups (Table 3).
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 46 65 46 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus anthracis </italic>
###xml 46 64 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 133 140 <span type="species:ncbi:1392">anthrax</span>
###xml 619 626 <span type="species:ncbi:1392">anthrax</span>
Since only a subset of individuals exposed to Bacillus anthracis spores develop pulmonary disease, the most life-threatening form of anthrax infection, it would be important to identify factors that lead to susceptibility to this type of infection. This might make it possible to identify those individuals who are at greatest risk and to provide them with the most aggressive treatment at the outset of infection. The ability to thus triage individuals in the case of a bioterrorism attack would be valuable. Moreover, understanding genetic susceptibility could lead to better management of individuals with pulmonary anthrax infection.
###end p 31
###begin p 32
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 397 416 397 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus anthracis </italic>
###xml 333 337 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 349 355 <span type="species:ncbi:9606">humans</span>
###xml 397 415 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 481 489 <span type="species:ncbi:9606">patients</span>
###xml 523 530 <span type="species:ncbi:1392">anthrax</span>
###xml 759 766 <span type="species:ncbi:1392">anthrax</span>
The genetic influences on resistance to infection are very strong. Indeed, genetic influences on resistance to infection appear to be greater than genetic influences on cancer or cardiovascular disease [45]. In the past few decades a considerable number of polymorphisms have been shown to cause infectious disease susceptibility in mice [6] and in humans [28,31,46]. Because infections caused by Bacillus anthracis are rare it was impossible to examine candidate polymorphisms in patients who actually developed pulmonary anthrax. Instead, it was necessary to use surrogate infections such as unusual mycobacterial infections, recurrent pneumonia, and tuberculosis or examine lung diseases such as sarcoidosis, which has been reported in cases of inhalation anthrax, for this study. The "lung disease group" in this study represented all the individuals with documented hospitalization for lung disease from a collection of 31,247 individuals of European, non-Hispanic origin unselected for any particular acute or chronic health problem. Candidate genes were chosen on the basis of their role in immunity against chronic infection as well as their participation in the innate immune response. This is a reasonable approach, since defects in the immune system generally increases susceptibility not to a single organism, but rather to multiple organisms that share some features in the pathogenesis of the disease that they produce.
###end p 32
###begin p 33
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p47 </italic>
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF1</italic>
###xml 58 66 58 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p67phox </italic>
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF2</italic>
###xml 74 82 74 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p40phox </italic>
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NCF4</italic>
###xml 90 98 90 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p22phox </italic>
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYBA</italic>
###xml 110 119 110 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gp91phox </italic>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYBB</italic>
###xml 186 192 186 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DUOX1 </italic>
###xml 196 197 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 199 203 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR2</italic>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 </italic>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AAT </italic>
###xml 450 468 450 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus anthracis</italic>
###xml 717 736 717 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus anthracis </italic>
###xml 750 756 750 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myD88 </italic>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 880 882 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 967 973 967 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BTNL2 </italic>
###xml 974 976 974 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 977 979 977 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 982 987 982 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL18 </italic>
###xml 988 990 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 997 1002 997 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFNa </italic>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1012 1020 1012 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC11A1 </italic>
###xml 1021 1023 1021 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 450 468 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 640 647 <span type="species:ncbi:1392">anthrax</span>
###xml 651 657 <span type="species:ncbi:9606">humans</span>
###xml 717 735 <span type="species:ncbi:1392">Bacillus anthracis</span>
Our analyses of genes of the NAD(P)H oxidase, p47 (NCF1), p67phox (NCF2), p40phox (NCF4), p22phox (CYBA), and gp91phox (CYBB), as well as other genes involved in innate immunity such as DUOX1 and 2, TLR2, TLR9 and AAT demonstrated that there were no differences between the control and lung disease group comprised of primarily sarcoidosis and tuberculosis individuals. There may, of course, be many other polymorphisms that affect susceptibility to Bacillus anthracis. Although the genes that we chose seemed to be reasonable candidates; there are many additional genes encoding products that could be important in effecting the course of anthrax in humans. For example, it has been suggested that susceptibility to Bacillus anthracis might involve myD88 [25]. Furthermore, susceptibility to infection by tuberculosis may be altered by variations in the vitamin D receptor gene [47]. Similarly, sarcoidosis has been shown to be associated with particular alleles in BTNL2 [48,49], IL18 [50], and IFNa [51], and SLC11A1 [52].
###end p 33
###begin title 34
Competing interests
###end title 34
###begin p 35
The author(s) declare that they have no competing interests.
###end p 35
###begin title 36
Authors' contributions
###end title 36
###begin p 37
Each author contributed substantially to the design, acquisition, and analysis of the data. PLL supervised the project and wrote the manuscript. Each author has read and approved the manuscript prior to submission.
###end p 37
###begin title 38
Acknowledgements
###end title 38
###begin p 39
This is manuscript number MEM18018. This work was supported by the CDC 5PO1 CI000095 and the Stein Endowment Fund. The authors would like to thank Dr. Jill Waalen for performing the power calculations and Drs. Ernest Beutler, Gary Bokoch, Bruce Beutler, Ulla Knaus, and Bruce Zuraw for their helpful discussions.
###end p 39
###begin article-title 40
###xml 26 33 <span type="species:ncbi:1392">anthrax</span>
Epidemiologic response to anthrax outbreaks: field investigations, 1950-2001
###end article-title 40
###begin article-title 41
###xml 11 18 <span type="species:ncbi:1392">anthrax</span>
Inhalation anthrax
###end article-title 41
###begin article-title 42
###xml 38 45 <span type="species:ncbi:1392">anthrax</span>
###xml 101 109 <span type="species:ncbi:9606">patients</span>
Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients
###end article-title 42
###begin article-title 43
###xml 47 54 <span type="species:ncbi:1392">anthrax</span>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Death due to bioterrorism-related inhalational anthrax: report of 2 patients
###end article-title 43
###begin article-title 44
###xml 40 58 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 69 73 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
The genetic basis of host resistance to Bacillus anthracis in inbred mice
###end article-title 44
###begin article-title 45
###xml 61 68 <span type="species:ncbi:1392">anthrax</span>
Characterization of macrophage sensitivity and resistance to anthrax lethal toxin
###end article-title 45
###begin article-title 46
Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases
###end article-title 46
###begin article-title 47
A p47-phox pseudogene carries the most common mutation causing p47-phox- deficient chronic granulomatous disease
###end article-title 47
###begin article-title 48
A complete physical contig and partial transcript map of the Williams syndrome critical region
###end article-title 48
###begin article-title 49
Identification of a novel NCF-1 (p47-phox) pseudogene not containing the signature GT deletion: significance for A47 degrees chronic granulomatous disease carrier detection
###end article-title 49
###begin article-title 50
NCF1 (p47phox) and ncf1 pseudogenes are not associated with inflammatory bowel disease
###end article-title 50
###begin article-title 51
Association between p47phox pseudogenes and inflammatory bowel disease
###end article-title 51
###begin article-title 52
###xml 81 85 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Positional identification of Ncf1 as a gene that regulates arthritis severity in rats
###end article-title 52
###begin article-title 53
###xml 93 98 <span type="species:ncbi:9606">human</span>
C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils
###end article-title 53
###begin article-title 54
###xml 66 71 <span type="species:ncbi:9606">human</span>
Functional effects of NAD(P)H oxidase p22(phox) C242T mutation in human leukocytes and association with thrombotic cerebral infarction
###end article-title 54
###begin article-title 55
Angiotensin-converting enzyme and p22(phox) polymorphisms and the risk of coronary heart disease in a low-risk Spanish population
###end article-title 55
###begin article-title 56
No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk
###end article-title 56
###begin article-title 57
Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense
###end article-title 57
###begin article-title 58
###xml 50 55 <span type="species:ncbi:9606">human</span>
Regulated hydrogen peroxide production by Duox in human airway epithelial cells
###end article-title 58
###begin article-title 59
Dual oxidase-2 has an intrinsic Ca2+-dependent H2O2-generating activity
###end article-title 59
###begin article-title 60
NADPH oxidase-dependent acid production in airway epithelial cells
###end article-title 60
###begin article-title 61
Identification of novel genes involved in congenital hypothyroidism using serial analysis of gene expression
###end article-title 61
###begin article-title 62
Persistent mild hypothyroidism associated with novel sequence variants of the DUOX2 gene in two siblings
###end article-title 62
###begin article-title 63
Three Mutations (p.Q36H, p.G418fsX482, and g.IVS19-2A>C) in the Dual Oxidase 2 Gene Responsible for Congenital Goiter and Iodide Organification Defect
###end article-title 63
###begin article-title 64
###xml 62 80 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 100 104 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
MyD88-dependent signaling contributes to protection following Bacillus anthracis spore challenge of mice: implications for Toll-like receptor signaling
###end article-title 64
###begin article-title 65
Induction of direct antimicrobial activity through mammalian toll-like receptors
###end article-title 65
###begin article-title 66
###xml 89 115 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis
###end article-title 66
###begin article-title 67
###xml 34 39 <span type="species:ncbi:9606">human</span>
The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease
###end article-title 67
###begin article-title 68
The importance of Toll-like receptor 2 polymorphisms in severe infections
###end article-title 68
###begin article-title 69
Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling
###end article-title 69
###begin article-title 70
###xml 106 114 <span type="species:ncbi:9606">patients</span>
Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients
###end article-title 70
###begin article-title 71
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 80 100 <span type="species:ncbi:139">Borrelia burgdorferi</span>
Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease
###end article-title 71
###begin article-title 72
###xml 110 131 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Lack of association between Toll-like receptor 2 polymorphisms and susceptibility to severe disease caused by Staphylococcus aureus
###end article-title 72
###begin article-title 73
Protease inhibitors in chronic obstructive pulmonary disease
###end article-title 73
###begin article-title 74
The multiple causes of alpha1-antitrypsin deficiency
###end article-title 74
###begin article-title 75
Pulmonary emphysema and alpha 1-antitrypsin deficiency
###end article-title 75
###begin article-title 76
Obstructive lung disease and alpha-1-antitrypsin deficiency gene heterozygosity
###end article-title 76
###begin article-title 77
Z and S mutations of the alpha1-antitrypsin gene and the risk of chronic obstructive pulmonary disease
###end article-title 77
###begin article-title 78
Lung function studies in asymptomatic individuals with moderately (Pi SZ) and severely (Pi Z) reduced levels of alpha1-antitrypsin
###end article-title 78
###begin article-title 79
###xml 23 31 <span type="species:ncbi:9606">patients</span>
Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy
###end article-title 79
###begin article-title 80
The protease inhibitor PI*S allele and COPD: a meta-analysis
###end article-title 80
###begin article-title 81
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Alpha1-antitrypsin deficiency allele carriers among lung cancer patients
###end article-title 81
###begin article-title 82
###xml 31 39 <span type="species:ncbi:9606">patients</span>
The effect of HFE genotypes in patients attending a health appraisal clinic
###end article-title 82
###begin article-title 83
A study of genes that may modulate the expression of hereditary hemochromatosis: Transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin
###end article-title 83
###begin article-title 84
Genetic and environmental influences on premature death in adult adoptees
###end article-title 84
###begin article-title 85
The role of red blood cell polymorphisms in resistance and susceptibility to malaria
###end article-title 85
###begin article-title 86
Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk
###end article-title 86
###begin article-title 87
The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites
###end article-title 87
###begin article-title 88
Sarcoidosis is associated with a truncating splice site mutation in BTNL2
###end article-title 88
###begin article-title 89
Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population
###end article-title 89
###begin article-title 90
Association between IFNA genotype and the risk of sarcoidosis
###end article-title 90
###begin article-title 91
Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland
###end article-title 91

